Literature DB >> 17653209

Podocyte biology in diabetic nephropathy.

J J Li1, S J Kwak, D S Jung, J-J Kim, T-H Yoo, D-R Ryu, S H Han, H Y Choi, J E Lee, S J Moon, D K Kim, D S Han, S-W Kang.   

Abstract

Glomerular visceral epithelial cells, namely podocytes, are highly specialized cells and give rise to primary processes, secondary processes, and finally foot processes. The foot processes of neighboring podocytes interdigitate, leaving between them filtration slits. These are bridged by an extracellular substance, known as the slit diaphragm, which plays a major role in establishing size-selective barrier to protein loss. Furthermore, podocytes are known to synthesize matrix molecules to the glomerular basement membrane (GBM), including type IV collagen, laminin, entactin, and agrin. Because diabetic nephropathy is clinically characterized by proteinuria and pathologically by glomerular hypertrophy and GBM thickening with foot process effacement, podocytes have been the focus in the field of research on diabetic nephropathy. As a result, many investigations have demonstrated that the diabetic milieu per se, hemodynamic changes, and local growth factors such as transforming growth factor-beta and angiotensin II, which are considered mediators in the pathogenesis of diabetic nephropathy, induce directly and/or indirectly hypertrophy, apoptosis, and structural changes, and increase type IV collagen synthesis in podocytes. This review explores some of the structural and functional changes of podocytes under diabetic conditions and their role in the development and progression of diabetic nephropathy.

Entities:  

Mesh:

Year:  2007        PMID: 17653209     DOI: 10.1038/sj.ki.5002384

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  76 in total

Review 1.  Building an atlas of gene expression driving kidney development: pushing the limits of resolution.

Authors:  S Steven Potter; Eric W Brunskill
Journal:  Pediatr Nephrol       Date:  2013-09-01       Impact factor: 3.714

2.  Potential application of nanoemulsified garlic oil blend in mitigating the progression of type 2 diabetes-mediated nephropathy in Wistar rats.

Authors:  Muralidaran Yuvashree; Rajesh Nachiappa Ganesh; Pragasam Viswanathan
Journal:  3 Biotech       Date:  2020-05-29       Impact factor: 2.406

3.  Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy.

Authors:  Brenda I Luna-Antonio; Rafael Rodriguez-Muñoz; Carmen Namorado-Tonix; Paula Vergara; Jose Segovia; Jose L Reyes
Journal:  Histochem Cell Biol       Date:  2017-03-18       Impact factor: 4.304

4.  The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.

Authors:  Khaled Khazim; Yves Gorin; Rita Cassia Cavaglieri; Hanna E Abboud; Paolo Fanti
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

5.  High glucose induces autophagy in podocytes.

Authors:  Tean Ma; Jili Zhu; Xinghua Chen; Dongqing Zha; Pravin C Singhal; Guohua Ding
Journal:  Exp Cell Res       Date:  2013-02-04       Impact factor: 3.905

6.  The Role of Palladin in Podocytes.

Authors:  Nadine Artelt; Tim A Ludwig; Henrik Rogge; Panagiotis Kavvadas; Florian Siegerist; Antje Blumenthal; Jens van den Brandt; Carol A Otey; Marie-Louise Bang; Kerstin Amann; Christos E Chadjichristos; Christos Chatziantoniou; Karlhans Endlich; Nicole Endlich
Journal:  J Am Soc Nephrol       Date:  2018-05-02       Impact factor: 10.121

7.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

8.  Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy.

Authors:  Chun-Liang Lin; Feng-Sheng Wang; Yen-Chen Hsu; Cheng-Nan Chen; Min-Jen Tseng; Moin A Saleem; Pey-Jium Chang; Jeng-Yi Wang
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

9.  Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.

Authors:  Elena Tarabra; Sara Giunti; Federica Barutta; Gennaro Salvidio; Davina Burt; Giacomo Deferrari; Roberto Gambino; Daniela Vergola; Silvia Pinach; Paolo Cavallo Perin; Giovanni Camussi; Gabriella Gruden
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

10.  Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

Authors:  Federica Barutta; Alessandro Corbelli; Raffaella Mastrocola; Roberto Gambino; Vincenzo Di Marzo; Silvia Pinach; Maria Pia Rastaldi; Paolo Cavallo Perin; Gabriella Gruden
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.